Michael Buhle
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Michael Buhle is President & Chief Executive Officer at Aspira Women's Health, Inc. since 2025.
Formerly, Mr. Buhle was Chief Commercial Officer at Biovision Diagnostics LLC from 2022 to 2024 and Vice President-Sales & Americas at Congenica Ltd. Mr. Buhle completed undergraduate studies at the University of Clarke.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ASPIRA WOMEN'S HEALTH INC. | Directeur Général | 21/02/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
Biovision Diagnostics LLC
Biovision Diagnostics LLC Medical/Nursing ServicesHealth Services Provides laboratory services | Corporate Officer/Principal | 01/12/2024 |
Congenica Ltd.
Congenica Ltd. Packaged SoftwareTechnology Services Operates as a digital health company that enables analysis of genomic data | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Aspira Women's Health, Inc.
Aspira Women's Health, Inc. BiotechnologyHealth Technology Develops and manufactures diagnostic test kits | Health Technology |
University of Clarke
University of Clarke Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Congenica Ltd.
Congenica Ltd. Packaged SoftwareTechnology Services Operates as a digital health company that enables analysis of genomic data | Technology Services |
Biovision Diagnostics LLC
Biovision Diagnostics LLC Medical/Nursing ServicesHealth Services Provides laboratory services | Health Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national